Table 3.
Prevalence of Parkinson's disease by age and location for both sexes.
| Age groups years (n) | 65–69Rate (CI) | 70–74Rate (CI) | 75–79Rate (CI) | 80 +Rate (CI) | TotalRate (CI) |
|---|---|---|---|---|---|
| Cuba | n = 757 | n = 789 | n = 627 | n = 730 | n = 2903 |
| Female (n = 1880) | 1.4 (0.7–3.0) | 1.8 (1.0–3.5) | 3.0 (1.7–5.2) | 3.4 (2.1–5.3) | 2.4 (1.8–3.2) |
| Male (n = 1023) | 0.7 (0.2–2.9) | 0.7 (0.2–2.7) | 2.2 (0.9–5.1) | 9.7 (6.5–14.3) | 3.0 (2.1–4.3) |
| Total (n = 2903) | 1.2 (0.6–2.2) | 1.4 (0.8–2.5) | 2.7 (1.71–4.3) | 5.3 (3.9–7.2) | 2.6 (2.1–3.3) |
| Dominican Republic | n = 516 | n = 494 | n = 368 | n = 457 | n = 1835 |
| Female (n = 1192) | 1.2 (0.5–3.1) | 1.3 (0.5–3.4) | 2.0 (0.8–04.7) | 2.3 (1.1–4.7) | 1.7 (1.1–2.6) |
| Male (n = 643) | 1.1 (0.3–4.3) | 1.6 (0.5–4.9) | 5.8 (2.8–11.8) | 4.5 (2.1–9.2) | 2.9 (1.9–4.6) |
| Total (n = 1835) | 1.2 (0.5–2.6) | 1.4 (0.7–2.9) | 3.3 (1.9–5.7) | 3.1 (1.82–5.1) | 2.1 (1.5–2.9) |
| Puerto Rico | n = 339 | n = 376 | n = 402 | n = 488 | n = 1, 605 |
| Female (n = 1084) | 1.2 (0.4–3.6) | 0.4 (0.1–2.8) | 2.6 (1.2–5.3) | 1.9 (0.8–4.2) | 1.6 (1.0–2.5) |
| Male (n = 521) | 0.0 | 1.6 (0.4–6.1) | 0.8 (0.1–5.2) | 2.8 (1.2–6.6) | 1.5 (0.8–3.1) |
| Total (n = 1605) | 0.9 (0.3–2.7) | 0.8 (0.3–2.4) | 2.0 (1.0–3.9) | 2.2 (1.3–4.0) | 1.6 (1.1–2.3) |
| Peru (urban) | n = 368 | n = 351 | n = 296 | n = 343 | n = 1358 |
| Female (n = 873) | 1.9 (0.8–4.5) | 1.4 (0.4–4.2) | 1.1 (0.3–4.1) | 1.0 (0.2–3.8) | 1.3 (0.7–2.4) |
| Male (n = 485) | 0.0 (0.0–0.0) | 0.8 (0.1–5.2) | 1.9 (0.5–7.2) | 2.2 (0.76.5) | 1.2 (0.5–2.7) |
| Total (n = 1358) | 1.4 (0.6–3.2) | 1.1 (0.4–3.0) | 1.4 (0.5–03.6) | 1.5 (0.6–3.4) | 1.2 (0.8–2.1) |
| Peru (rural) | n = 179 | n = 140 | n = 99 | n = 128 | n = 546 |
| Female (n = 291) | 1.0 (0.1–6.8) | 3.6 (1.2–10.8) | 0.0 (0.0–0.0) | 5.1 (1.6–15.0) | 2.4 (1.1–5.0) |
| Male (n = 255) | 1.3 (0.2–8.6) | 0.0 (0.0 – 0.0) | 0.0 (0.0 – 0.0) | 0.0 (0.0 – 0.0) | 0.4 (0.05–2.7) |
| Total (n = 546) | 1.1 (0.3–4.4) | 2.1 (0.7–6.5) | 0.0 (0.0 – 0.0) | 2.3 (0.7–7.1) | 1.4 (0.7–2.9) |
| Venezuela | n = 610 | n = 335 | n = 247 | n = 206 | n = 1398 |
| Female (n = 891) | 0.3 (0.04–1.8) | 1.9 (0.7–5.0) | 1.3 (0.7–4.9) | 4.9 (2.3–9.8) | 1.6 (0.9–2.6) |
| Male (n = 507) | 0.9 (0.2–3.5) | 2.4 (0.8–7.3) | 2.1 (0.5–8.1) | 6.5 (2.4–16.1) | 2.2 (1.2–3.9) |
| Total (n = 1398) | 0.5 (0.2–1.5) | 2.1 (1.0–4.3) | 1.6 (0.6–4.2) | 5.3 (3.0–9.4) | 1.8 (1.2–2.6) |
| Mexico(urban) | n = 243 | n = 326 | n = 203 | n = 211 | n = 981 |
| Female (n = 647) | 1.1 (0.3 - 4.3) | 3.8 (1.9–7.5) | 1.6 (0.4–6.3) | 3.8 (1.5–8.7) | 2.6 (1.6 - 4.2) |
| Male (n = 334) | 1.7 (0.2 −11.1) | 0.8 (0.2–5.8) | 1.3 (0.2–8.6) | 3.8 (1.2–11.3) | 1.8 (0.8 – 4.0) |
| Total (n = 981) | 1.2 (0.4–3.7) | 2.8 (1.4–5.2) | 1.5 (0.5–4.5) | 3.8 (1.9–7.4) | 2.3 (1.5 - 3.5) |
| México (rural) | n = 299 | n = 251 | n = 217 | n = 217 | n = 984 |
| Female (n = 590) | 1.0 (0.3–4.0) | 0.7 (0.09–4.6) | 2.3 (0.7–6.8) | 4.4 (01.8–10.2) | 1.9 (1.0–3.3) |
| Male (n = 394) | 1.0 (0.1–6.7) | 1.0 (0.1–6.6) | 1.2 (0.1–7.9) | 1.9 (0.5–7.4) | 1.3 (0.6–3.0) |
| Total (n = 984) | 1.0 (0.3–3.1) | 0.8 (0.2–3.1) | 1.8 (0.7–4.8) | 3.2 (1.5–6.6) | 1.6 (1.0–2.6) |
| All centres combined | n = 3308 | n = 3054 | n = 2459 | n = 2779 | n = 11, 610 |
| Female (n = 7444) | 1.1 (0.8–1.7) | 1.8 (1.2–2.4) | 2.1 (1.5–2.9) | 2.9 (2.2–3.8) | 1.9 (1.6–2.3) |
| Male (n = 4156) | 0.8 (0.4–1.6) | 1.1 (0.6–1.9) | 2.1 (1.4–3.3) | 4.6 (3.4–6.0) | 2.1 (1.7–2.6) |
| Total (n = 11,610) | 1.0 (0.7–1.4) | 1.5 (1.1–2.0) | 2.1 (1.6–2.7) | 3.5 (2.9–4.3) | 2.0 (1.7–2.3) |
The overall gender-specific prevalence rates are age adjusted to the whole sample as standard population. Numbers in parentheses indicates 95% Confidence Interval. CI=confidence interval.